Im Cannabis Corp. - Understand $imcc stock

$IMCC Market Cap: $6.92 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$48.34M

TTM

Gross Margin

17.54%

TTM

Net Earnings

-$14.52M

TTM

Current Assets

$19.97M

Q1 2024

Current Liabilities

$30.49M

Q1 2024

Current Ratio

65.5%

Q1 2024

Total Assets

$41.11M

Q1 2024

Total Liabilities

$31.59M

Q1 2024

Book Value

$9.519M

Q1 2024

Cash

$1.048M

Q1 2024

P/E

-0.4766

Nov 29, 2024 EST

Free Cash Flow

-$2.815M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995
Revenue	$48.80M	$54.34M	$54.30M	$15.89M	$9.074M	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-10.18%	0.06%	241.72%	75.12%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$48.80M	$54.34M	$54.30M	$15.89M	$9.074M	$0.00	$0.00	$0.00	$0.00	$0.00
Cost Of Revenue	$38.96M	$44.86M	$51.21M	$17.20M	$11.14M
Gross Profit	$9.846M	9.162M cads	$3.086M	-$1.313M	-$2.061M
Gross Profit Margin	20.17%	16.86%	5.68%	-8.26%	-22.71%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995
Selling, General & Admin	$22.02M	$35.57M	$48.69M	$18.58M	$10.34M	$117.4K	$123.4K	$15.25K	$43.96K	$149.8K
YoY Change	-38.09%	-26.94%	162.07%	79.68%	8704.39%	-4.85%	709.25%	-65.31%	-70.66%
% of Gross Profit	223.65%	388.23%	1577.61%
Research & Development				$136.0K	$233.0K				$0.00	$0.00
YoY Change				-41.63%
% of Gross Profit
Depreciation & Amortization	$2.996M	$7.331M	$5.729M	$930.0K	$601.0K			$0.00	$510.00	$0.00	$10.00K	$20.00K	$10.00K	$20.00K	$10.00K	$10.00K	$10.00K	$0.00	$0.00	$0.00	$0.00	$10.00K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-59.13%	27.96%	516.02%	54.74%				-100.0%		-100.0%	-50.0%	100.0%	-50.0%	100.0%	0.0%	0.0%					-100.0%
% of Gross Profit	30.43%	80.02%	185.64%
Operating Expenses	$22.02M	$35.57M	$48.68M	$18.71M	$10.57M	$122.7K	$125.0K	$15.25K	$47.73K	$79.61K
YoY Change	-38.09%	-26.94%	160.17%	77.01%	8518.24%	-1.84%	719.48%	-68.05%	-40.05%
Operating Profit	-$12.17M	-26.41M cads	-$45.60M	-$20.03M	-$12.63M
YoY Change	-53.9%	-42.09%	127.7%	58.52%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2017	2016	2015	2014
Interest Expense	$3.335M	$4.731M	$20.38M	-$20.23M	$2.946M	$0.00	-$500.00	-$440.00	$0.00
YoY Change	-29.51%	-76.78%	-200.74%	-786.59%		-100.0%	13.64%
% of Operating Profit
Other Income/Expense, Net
YoY Change

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Pretax Income	-$9.457M	-$26.06M	-$18.01M	-$28.47M	-$7.329M	-$122.7K	-$125.0K	-$15.75K	-$45.61K	-$80.05K
YoY Change	-63.71%	44.67%	-36.73%	288.48%	5874.57%	-1.84%	693.46%	-65.47%	-43.02%
Income Tax	$771.0K	-$1.138M	$505.0K	$262.0K	$90.00K
% Of Pretax Income
Net Earnings	-$9.498M	-191.3M cads	-$17.76M	-$28.70M	-$7.292M	-$122.7K	-$125.0K	-$15.75K	-$45.61K	-$37.69K
YoY Change	-95.04%	976.96%	-38.1%	293.55%	5844.4%	-1.84%	693.46%	-65.47%	21.01%
Net Earnings / Revenue	-19.46%	-352.08%	-32.71%	-180.6%	-80.36%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.74	-$26.30	-$306.5K	-$721.7K	-$228.0K	-$55.12K	-$231.5K	-$6.098K	-$4.415K	-$3.648K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995
Cash & Short-Term Investments	$1.813M	$2.449M	$17.03M	$8.885M	$13.93M	$37.00K	$4.030K	$170.00	$170.00	$5.740K	$0.00	$10.00K	$230.0K	$470.0K	$2.130M	$610.0K	$320.0K	$1.070M	$550.0K	$470.0K	$720.0K	$20.00K	$20.00K	$10.00K	$30.00K	$40.00K	$30.00K	$60.00K	$130.0K
YoY Change	-25.97%	-85.62%	91.69%	-36.2%	37537.84%	818.11%	2270.59%	0.0%	-97.04%		-100.0%	-95.65%	-51.06%	-77.93%	249.18%	90.63%	-70.09%	94.55%	17.02%	-34.72%	3500.0%	0.0%	100.0%	-66.67%	-25.0%	33.33%	-50.0%	-53.85%
Cash & Equivalents	$1.813M	$2.449M	$13.90M	$8.885M	$13.93M	$37.00K	$4.030K	$170.00	$170.00	$5.740K	$0.00			$470.0K	$2.130M	$610.0K			$360.0K	$250.0K	$720.0K	$20.00K	$20.00K	$10.00K	$30.00K	$40.00K	$30.00K	$60.00K	$130.0K
Short-Term Investments			$3.129M										$0.00				$280.0K	$1.030M	$190.0K	$230.0K
Other Short-Term Assets	$936.0K	$1.631M	$2.301M	$3.620M	$2.565M				$0.00	$0.00	$0.00	$0.00	$10.00K	$70.00K	$10.00K	$10.00K	$20.00K	$10.00K	$10.00K	$10.00K	$20.00K	$10.00K	$40.00K	$10.00K	$0.00	$0.00	$10.00K	$10.00K	$10.00K
YoY Change	-42.61%	-29.12%	-36.44%	41.13%								-100.0%	-85.71%	600.0%	0.0%	-50.0%	100.0%	0.0%	0.0%	-50.0%	100.0%	-75.0%	300.0%			-100.0%	0.0%	0.0%
Inventory	$9.976M	$16.59M	$31.08M	$8.448M	$5.474M
Prepaid Expenses
Receivables	$7.651M	$8.684M	$16.71M	$5.501M	$1.810M					$0.00	$0.00	$20.00K	$0.00	$0.00	$10.00K	$20.00K	$0.00	$0.00	$0.00	$20.00K	$10.00K	$10.00K	$20.00K	$20.00K	$40.00K	$60.00K	$660.0K	$170.0K	$340.0K
Other Receivables	$3.889M	$3.323M	$17.19M	$689.0K	$516.0K					$1.470K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$24.27M	$32.67M	$84.31M	$27.14M	$24.29M	$37.00K	$9.140K	$280.00	$280.00	$9.940K	$0.00	$30.00K	$240.0K	$540.0K	$2.150M	$640.0K	$350.0K	$1.080M	$560.0K	$500.0K	$750.0K	$30.00K	$90.00K	$40.00K	$60.00K	$110.0K	$690.0K	$240.0K	$470.0K
YoY Change	-25.73%	-61.25%	210.62%	11.74%	65551.35%	304.81%	3164.29%	0.0%	-97.18%		-100.0%	-87.5%	-55.56%	-74.88%	235.94%	82.86%	-67.59%	92.86%	12.0%	-33.33%	2400.0%	-66.67%	125.0%	-33.33%	-45.45%	-84.06%	187.5%	-48.94%
Property, Plant & Equipment	$6.365M	$7.150M	$48.43M	$6.467M	$4.415M	$0.00	$0.00	$0.00	$0.00	$6.160K	$20.00K	$60.00K	$9.470M	$2.040M	$1.820M	$20.00K	$50.00K	$10.00K	$20.00K	$60.00K	$40.00K	$170.0K	$300.0K	$660.0K	$0.00	$10.00K	$10.00K	$10.00K	$0.00
YoY Change	-10.98%	-85.24%	648.88%	46.48%					-100.0%	-69.2%	-66.67%	-99.37%	364.22%	12.09%	9000.0%	-60.0%	400.0%	-50.0%	-66.67%	50.0%	-76.47%	-43.33%	-54.55%		-100.0%	0.0%	0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.285M	$2.410M	$2.429M	$2.341M	$912.0K										$0.00	$430.0K	$0.00
YoY Change	-5.19%	-0.78%	3.76%	156.69%											-100.0%
Other Assets		$763.0K	$30.00K	$769.0K	$89.00K									$7.110M	$5.860M	$5.320M	$2.450M	$580.0K	$530.0K	$600.0K	$100.0K	$120.0K	$320.0K	$0.00
YoY Change		2443.33%	-96.1%	764.04%										21.33%	10.15%	117.14%	322.41%	9.43%	-11.67%	500.0%	-16.67%	-62.5%
Total Long-Term Assets	$24.55M	$28.00M	$203.1M	$10.97M	$6.603M	$0.00	$0.00	$0.00	$0.00	$6.160K	$30.00K	$60.00K	$9.470M	$9.150M	$7.670M	$5.770M	$2.500M	$590.0K	$540.0K	$650.0K	$130.0K	$290.0K	$620.0K	$660.0K	$980.0K	$1.380M	$2.780M	$2.640M	$2.540M
YoY Change	-12.34%	-86.21%	1750.7%	66.18%					-100.0%	-79.47%	-50.0%	-99.37%	3.5%	19.3%	32.93%	130.8%	323.73%	9.26%	-16.92%	400.0%	-55.17%	-53.23%	-6.06%	-32.65%	-28.99%	-50.36%	5.3%	3.94%
Total Assets	$48.81M	$60.68M	$287.4M	$38.12M	$30.89M	$37.00K	$9.140K	$280.00	$280.00	$16.10K	$30.00K	$90.00K	$9.710M	$9.690M	$9.820M	$6.410M	$2.850M	$1.670M	$1.100M	$1.150M	$880.0K	$320.0K	$710.0K	$700.0K	$1.040M	$1.490M	$3.470M	$2.880M	$3.010M
YoY Change
Accounts Payable	$15.44M	$21.33M	$13.99M	$2.605M	$992.0K	$250.9K	$255.2K	$196.2K	$180.9K	$167.7K	$290.0K	$220.0K	$0.00	$70.00K	$110.0K	$50.00K	$460.0K	$230.0K	$170.0K	$130.0K	$60.00K	$30.00K	$0.00	$80.00K	$0.00	$140.0K	$930.0K	$180.0K	$230.0K
YoY Change	-27.59%	52.44%	437.01%	162.6%	295.36%	-1.67%	30.07%	8.43%	7.91%	-42.19%	31.82%		-100.0%	-36.36%	120.0%	-89.13%	100.0%	35.29%	30.77%	116.67%	100.0%		-100.0%		-100.0%	-84.95%	416.67%	-21.74%
Accrued Expenses	$2.097M	$2.434M	$6.039M										$50.00K
YoY Change	-13.85%	-59.7%
Deferred Revenue
YoY Change
Short-Term Debt	$12.12M	$9.246M	$9.502M	$0.00	$0.00	$0.00	$0.00	$6.440K	$5.940K	$5.440K	$30.00K	$30.00K	$200.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$50.00K	$0.00	$0.00	$150.0K	$100.0K	$520.0K	$0.00	$0.00
YoY Change	31.07%	-2.69%					-100.0%	8.42%	9.19%	-81.87%	0.0%	-85.0%									-100.0%			-100.0%	50.0%	-80.77%
Long-Term Debt Due	$454.0K	$814.0K	$1.554M	$167.0K	$159.0K
YoY Change	-44.23%	-47.62%	830.54%	5.03%
Total Short-Term Liabilities	$32.81M	$33.82M	$51.23M	$6.269M	$2.609M	$251.6K	$466.0K	$432.2K	$416.4K	$386.6K	$320.0K	$250.0K	$270.0K	$70.00K	$110.0K	$50.00K	$460.0K	$230.0K	$280.0K	$130.0K	$110.0K	$100.0K	$190.0K	$160.0K	$240.0K	$230.0K	$1.450M	$180.0K	$230.0K
YoY Change	-2.99%	-33.98%	717.15%	140.28%	936.76%	-46.0%	7.83%	3.78%	7.71%	20.82%	28.0%	-7.41%	285.71%	-36.36%	120.0%	-89.13%	100.0%	-17.86%	115.38%	18.18%	10.0%	-47.37%	18.75%	-33.33%	4.35%	-84.14%	705.56%	-21.74%
Long-Term Debt	$1.209M	$1.474M	$18.21M	$823.0K	$891.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-17.98%	-91.91%	2112.88%	-7.63%
Other Long-Term Liabilities	$133.0K	$254.0K	$6.413M	$16.91M	$459.0K
YoY Change	-47.64%	-96.04%	-62.08%	3584.31%
Total Long-Term Liabilities	$1.342M	$1.728M	$24.63M	$17.73M	$1.350M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-22.34%	-92.98%	38.86%	1213.63%
Total Liabilities	$34.34M	$38.02M	$86.15M	$27.02M	$6.234M	$251.6K	-$11.34M	-$11.38M	-$11.39M	-$11.42M	-$3.190M	-$3.240M	$1.040M	$840.0K	$880.0K	$50.00K	$460.0K	$230.0K	$280.0K	$130.0K	$110.0K	$100.0K	$190.0K	$160.0K	$240.0K	$230.0K	$1.450M	$180.0K	$230.0K
YoY Change	-9.68%	-55.86%	218.86%	333.41%	2377.25%	-102.22%	-0.3%	-0.14%	-0.26%	258.06%	-1.54%	-411.54%	23.81%	-4.55%	1660.0%	-89.13%	100.0%	-17.86%	115.38%	18.18%	10.0%	-47.37%	18.75%	-33.33%	4.35%	-84.14%	705.56%	-21.74%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $6.9203 Million

About IM Cannabis Corp.

IM Cannabis Corp is a CA-based company operating in Pharmaceuticals industry. The company is headquartered in Toronto, Ontario and currently employs 95 full-time employees. The company went IPO on 2019-11-05. IM Cannabis Corp. is a Canada-based medical cannabis company. The firm operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), which has a cultivation license to breed, grow and supply medical cannabis products in Israel. The firm also operates medical cannabis retail pharmacies, online platforms, distribution centres and logistical hubs in Israel. The firm operates through Adjupharm GmbH in Europe, which is a medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage, and distribution licenses granted by German regulatory authorities that allow for import/export capability with requisite permits. The firm operates through Trichome and its subsidiaries Trichome JWC Acquisition Corp. and MYM Nutraceuticals Inc., where it cultivates and processes cannabis for the adult-use market at its Ontario and Nova Scotia facilities under the WAGNERS and Highland Grow brands.

Industry: Medicinal Chemicals & Botanical Products Peers: Lexaria Bioscience Corp.